CSIG-32. ACTIVATED Trk/Met PATHWAY IS A NOVEL RESISTANCE MECHANISM FOR CDK4/6 INHIBITORS THAT CAN BE TARGETED WITH A SPECIFIC SMALL MOLECULE INHIBITOR

Por Olmez, Inan, Purow, Benjamin
Publicado no Neuro Oncol (2017)

Adult-onset adrenoleukodystrophy presenting after chemotherapy: No black and white matter

Por Isaacs, David, Olmez, Inan, Claassen, Daniel O.
Publicado no Neurol Clin Pract (2014)

Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth

Por Olmez, Inan, Shen, Wangzhen, McDonald, Hayes, Ozpolat, Bulent
Publicado no J Cell Mol Med (2015)

Combined c-Met/Trk inhibition overcomes resistance to CDK4/6 inhibitors in Glioblastoma

Por Olmez, Inan, Zhang, Ying, Manigat, Laryssa, Benamar, Mouadh, Brenneman, Breanna, Nakano, Ichiro, Godlewski, Jakub, Bronisz, Agnieszka, Lee, Jeongwu, Abbas, Tarek, Abounader, Roger, Purow, Benjamin
Publicado no Cancer Res (2018)

CDK4/6 inhibition is more active against the glioblastoma proneural subtype

Por Li, Ming, Xiao, Aizhen, Floyd, Desiree, Olmez, Inan, Lee, Jeongwu, Godlewski, Jakub, Bronisz, Agnieszka, Bhat, Krishna P.L., Sulman, Erik P., Nakano, Ichiro, Purow, Benjamin
Publicado no Oncotarget (2017)

Combined CDK4/6 mTOR inhibition is synergistic against glioblastoma via multiple mechanisms

Por Olmez, Inan, Brenneman, Breanna, Xiao, Aizhen, Serbulea, Vlad, Benamar, Mouadh, Zhang, Ying, Manigat, Laryssa, Abbas, Tarek, Lee, Jeongwu, Nakano, Ichiro, Godlewski, Jakub, Bronisz, Agnieszka, Abounader, Roger, Leitinger, Norbert, Purow, Benjamin
Publicado no Clin Cancer Res (2017)

Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha

Por Olmez, Inan, Love, Shawn, Xiao, Aizhen, Manigat, Laryssa, Randolph, Peyton, McKenna, Brian D, Neal, Brian P, Boroda, Salome, Li, Ming, Brenneman, Breanna, Abounader, Roger, Floyd, Desiree, Lee, Jeongwu, Nakano, Ichiro, Godlewski, Jakub, Bronisz, Agnieszka, Sulman, Erik P, Mayo, Marty, Gioeli, Daniel, Weber, Michael, Harris, Thurl E, Purow, Benjamin
Publicado no Neuro Oncol (2018)